Loading…
Advancing outcomes in hepatocellular carcinoma through earlier diagnosis, smarter treatment sequencing, and coordinated multidisciplinary care.
Office bearers
Prof. Sanjaya Satapathy
Chair
MD · Liver Transplant
Why this SIG, right now
Why Now
HCC is the fastest rising cause of cancer-related mortality in many regions, driven by the global burden of MASLD, alcohol-associated liver disease, and viral hepatitis. Three key forces define this moment:
Despite clear guidelines, surveillance rates remain suboptimal. Many patients with cirrhosis are not screened regularly, leading to delayed diagnosis.
The treatment landscape has transformed with the introduction of:
Significant disparities persist in:
Join Hepatocellular Carcinoma (HCC) to read and participate in the discussion board.